This intermediate course focuses on providing current guidelines on neurologic death. Discussion includes factors that impact the determination of neurologic death for infants, children and adults.
Course created on June 9, 2022
- After this course, participants will be able to review the current guidelines for the determination of neurologic death.
- After this course, participants will be able to discuss differences in the determination of neurologic death for infants and children, and adults..
- After this course, participants will be able to recognize important factors that can impact the determination of neurologic death.
- After this course, participants will be able to explain specific issues that can provide challenges when determining neurologic death.
|5-20 Minutes||Define and review criteria to determine neurologic death|
|20-35 Minutes||Review differences between children and adults|
|35-45 Minutes||Review cases of diagnostic errors|
|45-50 Minutes||Review challenging cases|
|50-55 Minutes||Discuss terminology and communication issues related to neurologic death|
|55-60 Minutes||Summary, Q&A|
MD, FAAP, FCCM
Thomas A. Nakagawa, M.D., FAAP, FCCM, is a board-certified pediatric critical care specialist. He is a Professor of Pediatrics at The University of Florida College of Medicine and the Medical Director of the Pediatric Intensive Care Unit at Wolfson Children’s Hospital in Jacksonville, Florida. Dr. Nakagawa continues to serve as the Assistant Medical Director for Honorbridge Organ Donation Services in Durham, North Carolina. His previous academic and clinical appointments include Eastern Virginia Medical School, Wake Forest University School of Medicine, and Johns Hopkins All Children’s Hospital. He was a Professor of Anesthesiology and Critical Care at Wake Forest and Johns Hopkins All Children’s Hospital where he also served as the Division Chief, Medical Director for Pediatric Critical Care, and Medical Director for Respiratory Care.
Dr. Nakagawa is a national and international consultant for issues pertaining to pediatric organ and tissue donation and the determination of circulatory and neurologic death. He is actively involved with work in the area of organ and tissue donation, neurologic and circulatory determination of death, and ethical issues pertaining to end-of-life care. Dr. Nakagawa has served on national committees including the Secretary of Health and Human Services, Advisory Committee on Organ Transplantation (ACOT), the UNOS/OPTN Pediatric Transplant committee, and co-chair for the Organ Donation and Transplantation Alliance donor management task force committee. He was national faculty and co-chair for the Organ Donation and Transplantation Collaboratives sponsored by the U.S. Department of Health and Human Services, Health Resources and Service Administration (HRSA), and co-chaired three National Pediatric Organ Donations Summits in the US. He currently serves on the Board of Directors for the Organ Donation and Transplantation Alliance as the representative and liaison for the Society of Critical Care Medicine.
Dr. Nakagawa has authored more than 100 papers, book chapters, and editorials. He has published pediatric donor management and dosing guidelines utilized by organ procurement organizations nationally. Dr. Nakagawa is the lead author of the updated guidelines for the determination of brain death in infants and children from the Society of Critical Care Medicine, American Academy of Pediatrics (AAP), and the Child Neurology Society (CNS). He has been a consultant to the American Academy of Pediatrics for the revision of the pediatric organ donation and transplantation policy statement. His international work includes involvement with the expert panel for the Canadian Council for Donation and Transplantation, the Geneva Conference on Pediatric Donation, and the Canadian Pediatric Donation after Circulatory Death guideline.
Dr. Nakagawa is actively involved with the Society of Critical Care Medicine where he has held leadership positions including the Chair of the Pediatric Section Executive Steering Committee. He currently serves as the Pediatric Representative on the SCCM Council. Dr. Nakagawa is a well-renowned national and international speaker and has lectured in 17 countries. He has been recognized nationally and internationally for his leadership and involvement with ethical issues, end-of-life care, donation and transplantation, determination of death, and his work in the field of pediatric medicine.
Sponsor Disclosure: This Course is presented by Continued Respiratory Therapy.
Content Disclosure: This learning event does not focus exclusively on any specific product or service.
Course participation information
To ensure you are ready to participate, please complete our short Test Drive to prepare your computer to view the course.
Login and logout times will be recorded and documented.
Passing an online exam and completing a course evaluation will be required to earn continuing education credit.
Live Webinars allow presenter and participant interaction. The exam and course evaluation for these courses must be completed within 7 days of the event.
On-demand courses include texts, video and audio recordings of live webinars, and multimedia formats. The exam and course evaluation for on-demand courses must be completed within 30 days of course registration.
To participate in the course, complete the exam and course evaluation, and earn continuing education credit, you must be a Continued Respiratory Therapy member. Participants must complete the entire course; partial credit is not allowed.
Continued Respiratory Therapy is committed to ensuring accessibility to the widest possible audience. We are continually improving the user experience for everyone. If you have questions, requests, or would like to report an accessibility-related issue, please email firstname.lastname@example.org. We will review your request and respond in a timely manner.
Visit our Contact us page or give us a call if you have questions.
American Association for Respiratory Care
This non-traditional program has been approved for a maximum of 1 contact hour(s) Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425 N. MacArthur Blvd. Suite 100 Irving TX 75063. Course # 187390000
Continued Respiratory Therapy is an approved provider for CE Broker, provider #50-30700. This course is offered for 1.0 hours. If you are a licensed respiratory therapist in Florida, Louisiana, Mississippi or South Carolina, CE Broker may be of interest to you. For Florida respiratory therapists, this course is registered in the Direct Delivery of Respiratory Care Services category.
International Association for Continuing Education and Training
Continued, LLC, is accredited by the International Association for Continuing Education and Training (IACET). Continued complies with the ANSI/IACET Standard, which is recognized internationally as a standard of excellence in instructional practices. As a result of this accreditation, Continued is authorized to issue the IACET CEU. Continued, LLC, is authorized by IACET to offer 0.1 CEUs for this program.
We recognize that state CE requirements are constantly changing. If you have any questions regarding our courses and your state requirements, please contact us at 866-382-0799 or contact Customer Service.